期刊文献+

临床实验室定量测定室内质控界限设定的讨论 被引量:2

Discussion on setting control limit of internal quality control in clinical laboratory quantitative measurement
在线阅读 下载PDF
导出
摘要 目的讨论临床实验室定量测定室内统计质量控制程序中质控图控制界限的设定问题。方法使用SPSS14.0统计软件对血清清蛋白(ALB)、丙氨酸氨基转移酶(ALT)、肌酐(Cr)3个项目每月质控数据作正态性检验并与累积数作比较。结果 30组数据中有18个正态性检验不符合,30组均数t检验有20组差异具有统计学意义(P<0.05),因此短期内计算出的均数和标准差不能直接应用为质控图的控制限。结论临床实验室定量检测室内质量控制图控制限的设定应当按照CLSI的C24-A3文件指导,使用稳定时期大量质控数据得到的标准差估计值或6个月累积值作为新批号的标准差,并定期评估。 Objective To discuss the setting problem of control limit for quality control chart during the statistical quality con-trol procedure of clinical laboratory quantitative measurement.Methods The normality test of the monthly quality control data for 3 items of albumin (ALB),alanine aminotransferase (ALT)and creatinine (Cr)was performed by using the SPSS 14.0 statistical software and which was compared with the cumulated data.Results Among 30 groups of data,the normality test was inconformity in 18 groups,among 30 groups of mean t test,the differences in 20 groups showed statistical significance(P 〈0.05).Therefore,the calculated means and standard deviation(SD)in short term could not be directly set as the control limit of the quality control chart. Conclusion Setting the control limit of internal quality control in clinical laboratory quantitative measurement should be according to the guidance of C24-A3 document in CLSI.The SD estimated value obtained from large amount stable quality control data or the 6-month cumulative values is recommended to be used as SD of the new batch number,which should be regularly assessed.
出处 《国际检验医学杂志》 CAS 2014年第20期2818-2819,2822,共3页 International Journal of Laboratory Medicine
关键词 定量检测 室内质控 界限设定 quantitative measurement internal quality control limit setting
  • 相关文献

参考文献8

  • 1中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会.GB/T 20468临床实验室定量测定室内质量控制指南[M].秦皇岛:中国标准出版社,2006.
  • 2Clinical Laboratory Standards Institude. C24-A3 Statistical qualitycontrol for quantitative measurement procedures: principles anddefinitions: approved guideline[S]. Wayne,PA,USA:CLSI, 2006.
  • 3Westgard JO. Statistical quality control procedures[J]. Clin LabMed,2013,33(1):111-124.
  • 4Westgard JO, Barry PL, Hunt MR, et al. A multi-rule Shewhartchart for quality control in clinical chemistry [ J J. Clin Chem,1981,27(3):493-501.
  • 5王治国,居漪,王薇.临床检验质量规范[J].检验医学,2012,27(12):984-988. 被引量:22
  • 6何法霖,王薇,钟堃,王治国.临床血液学检验项目质量规范的研究[J].国际检验医学杂志,2012,33(18):2302-2302. 被引量:4
  • 7Westgard S. Prioritizing risk analysis quality control plans basedon Sigma-metrics[J]. Clin Lab Med, 2013 ,33(1) :41-53.
  • 8Westgard JO. Perspectives on quality control, risk management,and analytical quality management[J]. Clin Lab Med, 2013,33.

二级参考文献15

  • 1陈文祥,申子瑜,杨振华.临床检验分析质量指标的设定[J].中华检验医学杂志,2006,29(4):298-300. 被引量:51
  • 2Fraser CG. Biological variation: from principles to practice [M]. Washington DC : AACC Press,2001 : 29-66.
  • 3Fraser CG, Kallner A, Kenny D, et al. Introduction: strategies to set global quality specifications in laboratory medicine [ J 1. Scand J Clin Lab Invest, 1999,579 (7) :477-478.
  • 4Fraser CG. Optimum analytical performance for point of care tes ting[J]. Clin Chim Acta,2001,307(l/2) :37-43.
  • 5National Committee for Clinical Laboratory Standards. C28 A How to define and determine reference intervals in the clinical laboratory; approved guideline[S]. 2nd ed. Villanova, PA: National Committee for Clinical Laboratory Standards, 2000.
  • 6D'Orazio P,Burnett RW, Fogh-Anderson N, et al. Approved IF(;(; recommendation on reporting results for blood glucose [J]. Clin Chem,2005,51(9):1573 1576.
  • 7Fraser CG. Quality specifications in laboratory medicine[J]. Clin Bioehem Rev, 1996,17(2) 109-114.
  • 8彭明婷.血液分析仪质量控制的问题与对策[J].检验医学,2008,23(6):551-553. 被引量:24
  • 9贺端明,林该胃,任婷婷.新鲜全血对不同血细胞分析仪的比对试验[J].检验医学与临床,2011,8(2):145-147. 被引量:16
  • 10李祖兰,杨亮程,陈兴明,夏吉成,白小军,许永杰,周维军,李平,丛玉隆.血小板功能实验评价及分析前的质量控制[J].军医进修学院学报,2011,32(2):196-199. 被引量:6

共引文献24

同被引文献22

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部